AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
75 hedge funds and large institutions have $118M invested in Agile Therapeutics in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
30% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 27
Holders
75
Holding in Top 10
1
Calls
$1.46M
Puts
$388K
Top Buyers
| 1 | +$2.52M | |
| 2 | +$888K | |
| 3 | +$693K | |
| 4 |
Two Sigma Advisers
New York
|
+$261K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$254K |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$401K | |
| 3 | -$314K | |
| 4 |
Jane Street
New York
|
-$302K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$298K |